RTGN — RetinalGenix Technologies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for RetinalGenix Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.806 | -2.08 | -2.18 | -3.91 | -2.09 |
| Depreciation | |||||
| Non-Cash Items | 0.644 | 0.578 | 0.856 | 3.48 | 1.33 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.005 | 0.077 | 0.156 | 0.23 | 0.413 |
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.157 | -1.42 | -1.17 | -0.199 | -0.348 |
| Capital Expenditures | — | — | — | -0 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | — | -0 | 0 |
| Financing Cash Flow Items | 0.025 | -0.025 | 0 | 0.109 | 0.348 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.211 | 1.37 | 1.17 | 0.195 | 0.348 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.054 | -0.052 | 0.003 | -0.005 | -0 |